Effectiveness of Certolizumab Pegol in Treating Rheumatoid Arthritis Patients with Persistent Inflamed Residual Mono- or Oligosynovitis Resistant to Prior TNF-[alpha] Inhibitors

We report four cases of successful treatment with certolizumab pegol (CZP) of rheumatoid arthritis (RA) patients with persistent inflamed residual mono- or oligosynovitis resistant to prior TNF-α inhibitors. Although the patients were in a moderate disease activity, a low activity, or a remission of...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Case reports in rheumatology 2015-01, Vol.2015
Hauptverfasser:	Koarada, Syuichi, Tsuboi, Masahiko, Komine, Mitsunori, Nakao, Yoshinobu, Tokuda, Yukiko, Ono, Yukihide, Tashiro, Satoko, Maruyama, Akihito, Ono, Nobuyuki, Ohta, Akihide, Tada, Yoshifumi
Format:	Artikel
Sprache:	eng
Schlagworte:	Laboratories Polyethylene glycol Rheumatoid arthritis Rheumatology TNF inhibitors Tumor necrosis factor-TNF Wrist
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!